市場調査レポート

商品コード

1554268

電気生理学デバイス市場規模、シェア、成長分析：タイプ別、適応症別、最終用途別、地域別- 産業予測、2024年～2031年

Electrophysiology Devices Market Size, Share, Growth Analysis, By Type, By Indication (Atrial Fibrillation, Non-Atrial Fibrillation), By End-Use, By Region - Industry Forecast 2024-2031

出版日: 2024年09月07日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

電気生理学デバイスの世界市場規模は、2022年に60億9,000万米ドルと評価され、予測期間（2024-2031年）のCAGR 11.16%で、2023年の67億8,000万米ドルから2031年には158億1,000万米ドルに成長する見通しです。

心房細動（AF）のような心臓疾患の予防と治療の両方を目的とした電気生理学（EP）検査の採用が増加していることが、市場の成長を大きく後押ししています。心臓リズム管理機器の需要は、継続的なモニタリングの必要性と病院以外の環境でのこれらの機器の使用の増加により急増しています。座りがちなライフスタイル、喫煙、過度のアルコール摂取、その他のリスクなどの要因が、特にミレニアル世代で心不全、突然の心停止、心房細動の発生率を高めています。米国疾病予防管理センターは、2031年までに約1,210万人のアメリカ人が心房細動の影響を受けると予測しています。欧州では、心房細動は他の地域よりも一般的であり、欧州心臓病学会は、不整脈による突然の心停止が欧米諸国における主要な死因であると指摘しています。毎年、約1,000人に1人がこの疾患の影響を受けています。心臓不整脈の検出と管理に不可欠な電気生理学デバイスは、心臓病の有病率の増加により、利用が増加しています。モバイル心臓モニタリングや外来心電図（ECG）トラッキングの進歩により、植え込み型心臓装置の遠隔モニタリングやデータ保存がより身近なものとなっています。この動向は市場成長をさらに促進すると予想されます。さらに、クライオアブレーション、レーザー治療、超音波アブレーションなどの低侵襲手技へのシフトが、この分野の発展を後押ししています。例えば、2022年2月、Medtronic社は、小児患者の房室結節再入可能性頻拍（AVNRT）を管理するために設計されたFreezor &Freezor Xtra Cardiac Cryoablation Focal CathetersのFDA承認を取得しました。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Medtronic（Ireland）
Boston Scientific Corporation（US）
Abbott（US）
GE HealthCare（US）
Biotronik SE & Co. KG（Germany）
MicroPort Scientific Corporation（China）
Koninklijke Philips N.V.（Netherlands）
Siemens Healthineers（Germany）
CardioFocus Inc.（US）
LivaNova PLC（UK）
Penumbra, Inc.（US）
Stereotaxis, Inc.（US）
Advanced Cardiac Therapeutics, Inc.（US）
CathRx Ltd.（Australia）
Osypka Medical GmbH（Germany）
AngioDynamics, Inc.（US）
H2O.ai Inc.（US）
DataRobot, Inc.（US）
Clarifai, Inc.（US）
Darktrace plc（UK）
C3.ai, Inc.（US）

Product Code: SQMIG35A2420

Global Electrophysiology Devices Market size was valued at USD 6.09 billion in 2022 and is poised to grow from USD 6.78 billion in 2023 to USD 15.81 billion by 2031, at a CAGR 11.16 % during the forecast period (2024-2031).

The rising adoption of electrophysiology (EP) tests for both preventing and treating heart conditions like atrial fibrillation (AF) is significantly driving market growth. The demand for cardiac rhythm management equipment has surged due to the need for continuous monitoring and the increasing use of these devices in non-hospital environments. Factors such as sedentary lifestyles, smoking, excessive alcohol consumption, and other risks are contributing to higher incidences of heart failure, sudden cardiac arrest, and AF, particularly among millennials. The Centers for Disease Control and Prevention projects that approximately 12.1 million Americans will be affected by AF by 2031. In Europe, atrial fibrillation is more common than in other regions, with the European Society of Cardiology noting that sudden cardiac arrest due to irregular heart rhythms is a leading cause of death in Western countries. Annually, around one in every 1,000 people is impacted by this condition. Electrophysiology devices, essential for detecting and managing heart arrhythmias, are seeing increased usage due to the growing prevalence of heart disease. The advancements in mobile cardiac monitoring and ambulatory electrocardiogram (ECG) tracking are making remote monitoring of implanted cardiac devices and data storage more accessible. This trend is expected to further propel market growth. Moreover, the shift towards minimally invasive procedures, such as cryoablation, laser therapy, and ultrasonic ablation, is enhancing the sector's development. For instance, in February 2022, Medtronic received FDA approval for the Freezor & Freezor Xtra Cardiac Cryoablation Focal Catheters, designed for managing Atrioventricular Nodal Reentrant Tachycardia (AVNRT) in pediatric patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electrophysiology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electrophysiology Devices Market Segmental Analysis

The global electrophysiology device market is segmented based on Product, indication, end-use, and region. Based on type, the market is segmented into Ablation Catheters [Radiofrequency (RF) Ablation, Cryoablation, Pulse Field Ablation], Diagnostic Catheter, Laboratory Devices, Access Devices. Based on indication, the market is segmented into Atrial fibrillation, and Non-Atrial Fibrillation. Based on end-use the market is segmented into Inpatient Facilities, Outpatient Facilities, and Others. Based on region the global Electrophysiology Devices Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Electrophysiology Devices Market

The increasing incidence of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, is significantly driving the demand for electrophysiology devices. Accurate diagnosis and effective treatment of these conditions are crucial, and electrophysiological devices play a vital role in addressing these needs. As the prevalence of these arrhythmias rises, the reliance on advanced electrophysiology devices for precise diagnosis and management grows. These devices are essential for both detecting and treating complex cardiac irregularities, further boosting their market demand.

Restraints in the Global Electrophysiology Devices Market

The high cost of electrophysiology devices can be a significant barrier to their widespread adoption, especially in areas with constrained healthcare budgets or stringent reimbursement policies. This financial constraint often limits access to these advanced technologies in less affluent regions or healthcare systems with restrictive funding. Due to their expense, the market for electrophysiology devices faces challenges related to affordability and accessibility. The substantial investment required for these devices can restrict their use, particularly in settings where budget limitations or stringent reimbursement policies are prevalent.

Market Trends of the Global Electrophysiology Devices Market

The field of electrophysiology is increasingly leaning towards minimally invasive procedures. Technological advancements and innovations in device design have led to the development of catheter-based techniques that offer precise diagnosis and treatment of cardiac arrhythmias, all while minimizing patient discomfort. These advanced techniques contribute to shorter recovery periods and a reduced risk of complications. By focusing on minimally invasive approaches, the field aims to enhance patient outcomes and streamline the overall treatment process.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Value Chain Analysis
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Porter's Five Forces Analysis
Patent Analysis
Pricing Analysis
Technology Analysis
Raw Material Analysis
Supply Chain Analysis

Global Electrophysiology Devices Market by Type

Market Overview
Ablation Catheters
- Radiofrequency (RF)Ablation
- Cryoablation, Pulse Field Ablation
Diagnostic Catheter
Laboratory Devices
Access Devices

Global Electrophysiology Devices Market by Indication

Market Overview
Atrial fibrillation
Non-Atrial Fibrillation

Global Electrophysiology Devices Market by End User

Market Overview
Inpatient Facilities
Outpatient Facilities
Others

Global Electrophysiology Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE HealthCare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CardioFocus Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stereotaxis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Cardiac Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CathRx Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka Medical GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
H2O.ai Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DataRobot, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clarifai, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Darktrace plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C3.ai, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

電気生理学デバイス市場規模、シェア、成長分析：タイプ別、適応症別、最終用途別、地域別- 産業予測、2024年～2031年

Electrophysiology Devices Market Size, Share, Growth Analysis, By Type, By Indication (Atrial Fibrillation, Non-Atrial Fibrillation), By End-Use, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

電気生理学デバイス市場：タイプ別

電気生理学デバイス市場：適応症別

電気生理学デバイス市場：最終用途別

電気生理学デバイス市場規模：地域別